Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

905 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Decitabine dosing schedules.
Kantarjian HM, Issa JP. Kantarjian HM, et al. Semin Hematol. 2005 Jul;42(3 Suppl 2):S17-22. doi: 10.1053/j.seminhematol.2005.05.006. Semin Hematol. 2005. PMID: 16015500 Review.
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO, et al. Estey EH, et al. Among authors: kantarjian hm. Blood. 1992 Feb 15;79(4):882-7. Blood. 1992. PMID: 1346577
Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.
Anaissie E, Kontoyiannis DP, Kantarjian H, Elting L, Robertson LE, Keating M. Anaissie E, et al. Among authors: kantarjian h. Ann Intern Med. 1992 Sep 15;117(6):466-9. doi: 10.7326/0003-4819-117-6-466. Ann Intern Med. 1992. PMID: 1354425
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.
Kantarjian HM, Keating MJ, Estey EH, O'Brien S, Pierce S, Beran M, Koller C, Feldman E, Talpaz M. Kantarjian HM, et al. J Clin Oncol. 1992 May;10(5):772-8. doi: 10.1200/JCO.1992.10.5.772. J Clin Oncol. 1992. PMID: 1569449
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.
Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keating M. Estey E, et al. Among authors: kantarjian h. Blood. 1992 May 1;79(9):2246-55. Blood. 1992. PMID: 1571541
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
Keating MJ, Estey E, Kantarjian H, Plunkett W, O'Brien S, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. Leukemia. 1992;6 Suppl 2:78-80. Leukemia. 1992. PMID: 1578950 Review. No abstract available.
CI-973, a new platinum derivative with potential antileukemic activity.
O'Brien S, Kantarjian H, Freireich E, Johnston D, Nguyen K, Beran M. O'Brien S, et al. Among authors: kantarjian h. Cancer Res. 1992 Aug 1;52(15):4130-4. Cancer Res. 1992. PMID: 1638526
Fludarabine therapy in macroglobulinemic lymphoma.
Kantarjian HM, Alexanian R, Koller CA, Kurzrock R, Keating MJ. Kantarjian HM, et al. Blood. 1990 May 15;75(10):1928-31. Blood. 1990. PMID: 1692487
Fludarabine phosphate therapy in other lymphoid malignancies.
Kantarjian HM, Redman JR, Keating MJ. Kantarjian HM, et al. Semin Oncol. 1990 Oct;17(5 Suppl 8):66-70. Semin Oncol. 1990. PMID: 1699285 Review.
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB. Keating MJ, et al. Among authors: kantarjian h. J Clin Oncol. 1991 Jan;9(1):44-9. doi: 10.1200/JCO.1991.9.1.44. J Clin Oncol. 1991. PMID: 1702145 Clinical Trial.
905 results
Jump to page
Feedback